Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Very High Efficacy of Stem Cell Mobilization Using Intermadiate-Dose Cytosine Arabinoside + G-CSF in Patients with Lymphoid Malignancies, Including Predicted and Proven Poor Mobilizers

Tomasz Kruzel, Tomasz Czerw, MD, Maria Sadus-Wojciechowska, MD, Jacek Najda, MD, Magdalena Glowala-Kosinska, PhD, Agata Chwieduk, PhD, Iwona Mitrus, PhD, Andrzej Smagur, PhD, Jerzy Holowiecki, MD, PhD, Sebastian Giebel, MD

Blood (2012) 120 (21): 4131.

https://doi.org/10.1182/blood.V120.21.4131.4131

Published: 2012

Journal Articles

Autologous Peripheral Blood Progenitor Cells Cryopreserved in 7.5% DMSO Give Faster Hematopoietic Reconstitution Than Cells Cryopreserved in 10% DMSO.

Iwona Mitrus, PhD, Andrzej Smagur, PhD, Sebastian Giebel, MD, Joanna Gliwinska, Magdalena Prokop, Agata Chwieduk, PhD, Magdalena Glowala-Kosinska, PhD, Maria Sadus-Wojciechowska, MD, Jerzy Holowiecki, MD, PhD

Blood (2012) 120 (21): 3018.

https://doi.org/10.1182/blood.V120.21.3018.3018

Published: 2012

Journal Articles

Evaluation of the Toxicity of Total Body Irradation As a Separate Treatment in Preparation for Hematopoietic Cell Transplantation

Sebastian Giebel, MD, Tomasz Kruzel, Maria Sadus-Wojciechowska, MD, Jacek Najda, MD, Tomasz Czerw, MD, Leszek Miszczyk, MD, PhD, Jerzy Holowiecki, MD, PhD

Blood (2011) 118 (21): 4579.

https://doi.org/10.1182/blood.V118.21.4579.4579

Published: 2011

Journal Articles

Increasing Efficacy of Autologous Haematopoetic Cell Transplantation in Acute Myeloblastic Leukaemia; a Single Centre Experience in 141 Patients.

Jerzy Holowiecki Prof, Tomasz Czerw, MD, Jerzy Wojnar, MD, PhD, Malgorzata Krawczyk-Kulis, MD, PhD, Sebastian Grosicki, MD, Beata Stella-Holowiecka, MD, PhD, Slawomira Kyrcz-Krzemien Prof, Maria Sadus-Wojciechowska, MD, Sebastian Giebel, MD, Lucja Kachel, MD, Krzysztof Wozniczka, MD, Aleksandra Holowiecka-Goral, MD

Blood (2007) 110 (11): 2875.

https://doi.org/10.1182/blood.V110.11.2875.2875

Published: 2007

Journal Articles

The Reduction of Leukemic Blasts in Bone Marrow Aspirate on Day 6 of Remission Induction Treatment Is Predictive for Complete Remission Rate and Survival in Adult Acute Myeloid Leukemia; the Results of Multicenter, Prospective Polish Adult Leukemia Group Trial.

Jerzy Holowiecki, Sebastian Grosicki, MD, Slawomira Kyrcz-Krzemien, Kazimierz Kuliczkowski, Marek Kielbinski, MD, Aleksander B. Skotnicki, Beata Jakubas, MD, Andrzej Hellmann, Tadeusz Robak, Marek J. Seweryn, MD, Beata Stella-Holowiecka, MD, Maria Sadus-Wojciechowska, MD

Blood (2007) 110 (11): 4375.

https://doi.org/10.1182/blood.V110.11.4375.4375

Published: 2007

Journal Articles

Autologous Transplantation of Non-Cryopreserved Bone Marrow for the Treatment of High-Risk Adult Acute Lymphoblastic Leukemia in First Complete Remission.

Jerzy Holowiecki, Sebastian Giebel, MD, Malgorzata Krawczyk-Kulis, MD, Maria Sadus-Wojciechowska, MD, Lucja Kachel, MD, Jerzy Wojnar, MD, Beata Stella-Holowiecka, MD, Sebastian Grosicki, MD

Blood (2005) 106 (11): 5492.

https://doi.org/10.1182/blood.V106.11.5492.5492

Published: 2005

Journal Articles

Lower Relapse Incidence after Non-Cryopreserved Autologous Bone Marrow Transplantation Compared to Peripheral Blood Stem Cell Transplantation for High-Risk Hodgkin’s Lymphoma.

Jerzy Holowiecki, Sebastian Giebel, MD, Malgorzata Krawczyk-Kulis, MD, Jerzy Wojnar, MD, Lucja Kachel, MD, Maria Sadus-Wojciechowska, MD, Beata Stella-Holowiecka, MD, Sebastian Grosicki, MD, Tomasz Czerw, MD

Blood (2004) 104 (11): 912.

https://doi.org/10.1182/blood.V104.11.912.912

Published: 2004

NARROW

Very High Efficacy of Stem Cell Mobilization Using Intermadiate-Dose Cytosine Arabinoside + G-CSF in Patients with Lymphoid Malignancies, Including Predicted and Proven Poor Mobilizers

Autologous Peripheral Blood Progenitor Cells Cryopreserved in 7.5% DMSO Give Faster Hematopoietic Reconstitution Than Cells Cryopreserved in 10% DMSO.

Evaluation of the Toxicity of Total Body Irradation As a Separate Treatment in Preparation for Hematopoietic Cell Transplantation

Increasing Efficacy of Autologous Haematopoetic Cell Transplantation in Acute Myeloblastic Leukaemia; a Single Centre Experience in 141 Patients.

The Reduction of Leukemic Blasts in Bone Marrow Aspirate on Day 6 of Remission Induction Treatment Is Predictive for Complete Remission Rate and Survival in Adult Acute Myeloid Leukemia; the Results of Multicenter, Prospective Polish Adult Leukemia Group Trial.

Autologous Transplantation of Non-Cryopreserved Bone Marrow for the Treatment of High-Risk Adult Acute Lymphoblastic Leukemia in First Complete Remission.

Lower Relapse Incidence after Non-Cryopreserved Autologous Bone Marrow Transplantation Compared to Peripheral Blood Stem Cell Transplantation for High-Risk Hodgkin’s Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Very High Efficacy of Stem Cell Mobilization Using Intermadiate-Dose Cytosine Arabinoside + G-CSF in Patients with Lymphoid Malignancies, Including Predicted and Proven Poor Mobilizers

Autologous Peripheral Blood Progenitor Cells Cryopreserved in 7.5% DMSO Give Faster Hematopoietic Reconstitution Than Cells Cryopreserved in 10% DMSO.

Evaluation of the Toxicity of Total Body Irradation As a Separate Treatment in Preparation for Hematopoietic Cell Transplantation

Increasing Efficacy of Autologous Haematopoetic Cell Transplantation in Acute Myeloblastic Leukaemia; a Single Centre Experience in 141 Patients.

The Reduction of Leukemic Blasts in Bone Marrow Aspirate on Day 6 of Remission Induction Treatment Is Predictive for Complete Remission Rate and Survival in Adult Acute Myeloid Leukemia; the Results of Multicenter, Prospective Polish Adult Leukemia Group Trial.

Autologous Transplantation of Non-Cryopreserved Bone Marrow for the Treatment of High-Risk Adult Acute Lymphoblastic Leukemia in First Complete Remission.

Lower Relapse Incidence after Non-Cryopreserved Autologous Bone Marrow Transplantation Compared to Peripheral Blood Stem Cell Transplantation for High-Risk Hodgkin’s Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only